June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Intermediate (CD14++CD16+) monocytes are expanded in non-infectious uveitis patients and have a reduced capacity to drive Th17 differentiation.
Author Affiliations & Notes
  • Emily Louisa Williams
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom
  • Baoying Liu
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD
  • Ashwin Dhanda
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom
  • Philippa J P Lait
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom
  • Lauren P Schewitz-Bowers
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom
  • Peter Collins
    University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
  • Andrew D Dick
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom
  • Robert B Nussenblatt
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD
    Centre for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health, Bethesda, MD
  • Richard W J Lee
    School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships Emily Williams, None; Baoying Liu, None; Ashwin Dhanda, None; Philippa Lait, None; Lauren Schewitz-Bowers, None; Peter Collins, None; Andrew Dick, None; Robert Nussenblatt, None; Richard Lee, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 852. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emily Louisa Williams, Baoying Liu, Ashwin Dhanda, Philippa J P Lait, Lauren P Schewitz-Bowers, Peter Collins, Andrew D Dick, Robert B Nussenblatt, Richard W J Lee; Intermediate (CD14++CD16+) monocytes are expanded in non-infectious uveitis patients and have a reduced capacity to drive Th17 differentiation.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):852.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Human monocyte subsets are phenotypically distinct and differ in their ability to stimulate T cells. It is unclear whether the proportion and function of monocyte subsets is skewed under inflammatory conditions or influenced by glucocorticoid treatment, thereby promoting or regulating tissue inflammation. The purpose of this project was therefore to characterise human monocyte subsets in the context of non-infectious uveitis and to interrogate their effect on CD4+ T cell phenotype and response to glucocorticoids.

Methods: The proportion of classical (CD14++CD16-), non-classical (CD14dimCD16++) and intermediate monocyte (CD14++CD16+) subsets in the peripheral blood (PB) of patients with non-infectious uveitis was determined by flow cytometry (n=98). As these patients were receiving immunosuppressive therapy, monocyte subsets were similarly assessed in treatment naïve alcoholic hepatitis patients as comparators (n=19). Classical and intermediate monocytes were isolated from the PB of healthy volunteers by fluorescent activated cell sorting (n=14). These subsets were co-cultured for 5 days with autologous memory CD4+CD45RO+ T cells, in the presence or absence of the synthetic glucocorticoid Dexamethasone (Dex). T cell proliferation and intracellular cytokine expression was then quantified.

Results: Analysis of monocyte subsets in the PB of patients showed that intermediate monocytes were enriched in both conditions. Following glucocorticoid treatment, intermediate monocytes were further expanded in non-infectious uveitis patients. During co-culture, intermediate monocytes induced less memory T cell proliferation (29% v 41%; p=0.003), less IL-17 expression (8% v 12%; p<0.001) but similar IFNγ production (27% v 26%) than classical monocytes. Dex-mediated suppression of T cell proliferation and IFNγ production was abrogated to a greater degree in intermediate monocyte co-cultures than in classical monocyte co-cultures. T cell proliferation and IL-17 production was also reduced in co-cultures containing both monocyte subsets compared with co-cultures containing classical monocytes alone.

Conclusions: Intermediate monocytes are expanded in the PB of patients with non-infectious uveitis and have a reduced capacity to drive memory T cell proliferation and IL-17 production. This is associated with enhanced T cell suppression by glucocorticoids.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×